Utilizing ChatGPT for assessing disease volume in patients (pts) with metastatic prostate cancer (mPC).
Abstract
42 Background: Artificial intelligence (AI) has transformed many aspects of healthcare, particularly in medical imaging analysis. In mPC, accurate identification of bone metastases is crucial in guiding pt management. This proof-of-concept study explores the application of ChatGPT-4o, a multimodal, generative pre-trained transformer (large language model) with emerging image recognition capabilities, in diagnosing bone metastases from bone scans and determining disease volume in pts with mPC. Methods: In this IRB-approved, retrospective study, pts with newly diagnosed mPC and bone-predominant disease were randomly selected. Those who had previously received bone-protecting agents, chemotherapy, hormone therapy, or radiation therapy prior to the bone scan were excluded. Using CHAARTED criteria, high-volume versus low-volume bone disease was classified based on radiologist reports. The bone scan images were then uploaded to ChatGPT, which was instructed to act as a radiologist and asked to classify the disease volume. ChatGPT's classifications were compared to the radiologists’ findings by using Cohen’s Kappa test. Confusion’s matrix was used to represent the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of ChatGPT. Results: A total of 110 pts were selected, with a median age of 67 years (range: 44 to 89). The majority were Caucasian (98.2%). The median Gleason score was 9, and 77.3% of pts had de novo metastatic disease. The median PSA value at diagnosis was 35.2 ng/ml (range: 1-5843). High-volume disease was present in 52% of pts. ChatGPT's overall concordance with radiologists was 74% (Cohen's Kappa = 0.65). For high-volume disease, ChatGPT demonstrated a high sensitivity of 92.3% (48/52). However, it misclassified 45.8% of low-volume cases as high-volume (specificity: 54.2%). The PPV and NPV of ChatGPT were 68.6% and 86.7%, respectively. Interestingly, ChatGPT’s accuracy was significantly higher when each case was analyzed individually (77.7%) compared to when cases were grouped in a single conversation (43.5%, p<0.001). Conclusions: This hypothesis-driven research demonstrated that ChatGPT-4o has the potential to read medical images independently and apply existing knowledge, such as the CHAARTED criteria, to assist in content generation. However, its reliability remains a significant challenge for broader use in healthcare. Notably, it exhibited "information fatigue," where accuracy significantly declined when similar or repetitive information accumulated within a single conversation.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (15)
Diya Garg
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
Micah Ostrowski
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
Ayana Srivastava
Huntsman Cancer Institute at The University of Utah, Salt Lake City, UT
Beverly Chigarira
3IntegraConnect PrecisionQ, West Palm Beach, United States
Yeonjung Jo
Huntsman Cancer Institute at The University of Utah, Salt Lake City, UT
Zeynep Irem Ozay
Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA
Chadi Hage Chehade
Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA
Georges Gebrael
Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA
Nicolas Sayegh
Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA
Gliceida Galarza Fortuna
15The University of Utah Huntsman Cancer Institute, Salt Lake City, United States
Vinay Mathew Thomas
Huntsman Cancer Institute at The University of Utah, Salt Lake City, UT
Benjamin L. Maughan
University of Utah, Salt Lake City, UT
Umang Swami
Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA
Neeraj Agarwal
Division of Medical Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City Utah USA
Haoran Li
Zhejiang University , , 866 Yuhangtang Rd , ,